| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +556K | 38.7% | $13.50 | +$7.5M |
| Sells | 4 | -882K | 61.3% | $12.91 | -$11.4M |
| Net | -3 | -326K | -22.7% | -$3.88M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Brian Taylor Slingsby | Director, 10%+ Owner | $113M | -$7.18M | -5.98% | Jul 24, 2024 |
| Samsara BioCapital GP, LLC | 10%+ Owner | $68.5M | +$7.5M | +12.3% | Feb 12, 2024 |
| Srinivas Akkaraju | Director, 10%+ Owner | $68.5M | May 22, 2024 | ||
| Ra Capital Management, L.P. | Director | $47.7M | May 22, 2024 | ||
| HBM Healthcare Investments (Cayman) Ltd. | 10%+ Owner | $19.2M | Feb 14, 2023 | ||
| Jon Congleton | Chief Executive Officer, Director | $7.95M | -$2.1M | -20.9% | Jan 13, 2025 |
| Adam Levy | CFO and Secretary | $2.18M | -$1.64M | -42.9% | Jan 13, 2025 |
| David Malcom Rodman | Chief Medical Officer | $171K | -$468K | -73.3% | Jan 13, 2025 |
| Daphne Karydas | Director | May 22, 2024 | |||
| Derek DiRocco | Director | May 22, 2024 | |||
| Alexander Asam | Director | Feb 9, 2023 | |||
| Glenn Sblendorio | Director | May 22, 2024 | |||
| Alexander M. Gold | Director | Jun 13, 2024 | |||
| Olivier Litzka | Director | May 22, 2024 | |||
| Takeshi Takahashi | Director | Jul 12, 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|